What's in HELSINN HLTHCARE's pipeline?

HELSINN HLTHCARE has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with HELSINN HLTHCARE's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/helsinn-hlthcare.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

HELSINN HLTHCARE — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HELSINN HLTHCARE pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Truseltiq	INFIGRATINIB	marketed		Fibroblast growth factor receptor 2	Oncology	2019-01-01
Akynzeo	FOSNETUPITANT	marketed	Serotonin-3 Receptor Antagonist [EPC]	Substance-P receptor	Oncology	2018-01-01
Akynzeo	NETUPITANT	marketed	Serotonin-3 Receptor Antagonist [EPC]	Substance-P receptor	Oncology	2014-01-01

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

2030-11-18 — Akynzeo · 9943515 · US
2030-11-18 — Akynzeo · 9186357 · US
2030-11-18 — Akynzeo · 9186357 · US
2030-11-18 — Akynzeo · 8951969 · US
2030-11-18 — Akynzeo · 8623826 · US
2030-11-18 — Akynzeo · 11559523 · US
2030-12-17 — Akynzeo · 10828297 · US
2030-12-17 — Akynzeo · 10828297 · US
2031-09-09 — Akynzeo · 9271975 · US
2032-05-23 — Akynzeo · 10208073 · US
2032-05-23 — Akynzeo · 11312698 · US
2032-05-23 — Akynzeo · 8426450 · US
2032-05-23 — Akynzeo · 10717721 · US
2032-05-23 — Akynzeo · 8895586 · US
2032-05-23 — Akynzeo · 9403772 · US
2032-05-23 — Akynzeo · 9908907 · US
2035-09-25 — Akynzeo · 10676440 · US
2035-09-25 — Akynzeo · 10233154 · US
2035-09-25 — Akynzeo · 10961195 · US
2035-09-25 — Akynzeo · 9951016 · US
2037-06-02 — Akynzeo · 11529362 · US
2037-06-02 — Akynzeo · 10624911 · US

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for HELSINN HLTHCARE:

Cite this brief

Drug Landscape (2026). HELSINN HLTHCARE — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/helsinn-hlthcare. Accessed 2026-05-16.